Posted in | News | Business

AirGas Board to Review Take Over Offer from Air Products

Airgas, Inc. (NYSE:ARG) today confirmed that Air Products & Chemicals, Inc. (NYSE:APD) has commenced an unsolicited tender offer to acquire all outstanding common shares of Airgas at a price of $60.00 per share in cash.

Consistent with its fiduciary duties and as required by applicable law, the Airgas Board of Directors will review the offer to determine the course of action that it believes is in the best interests of the Company and its stockholders. Airgas stockholders are advised to take no action at this time pending the review of the tender offer by the Airgas Board of Directors.

The Airgas Board of Directors, in consultation with its independent financial and legal advisors, intends to advise stockholders of its formal position regarding the offer within ten business days by making available to stockholders and filing with the Securities and Exchange Commission a solicitation/recommendation statement on Schedule 14D-9.

Airgas noted that the tender offer is identical in all material respects to the proposal received from Air Products on February 4, 2010 and that Airgas rejected on February 9, 2010.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Air Products PLC. (2019, March 18). AirGas Board to Review Take Over Offer from Air Products. AZoM. Retrieved on July 14, 2024 from https://www.azom.com/news.aspx?newsID=20672.

  • MLA

    Air Products PLC. "AirGas Board to Review Take Over Offer from Air Products". AZoM. 14 July 2024. <https://www.azom.com/news.aspx?newsID=20672>.

  • Chicago

    Air Products PLC. "AirGas Board to Review Take Over Offer from Air Products". AZoM. https://www.azom.com/news.aspx?newsID=20672. (accessed July 14, 2024).

  • Harvard

    Air Products PLC. 2019. AirGas Board to Review Take Over Offer from Air Products. AZoM, viewed 14 July 2024, https://www.azom.com/news.aspx?newsID=20672.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.